PSYONIC
Component
Maker of the Ability Hand: a 490 g, touch-sensing bionic hand with 32 grip patterns, also pitched as a robot end-effector.
PSYONIC sells the Ability Hand, a multi-articulated bionic hand for people with transradial limb difference: 490 g (lighter than an average adult hand), all five fingers flex and extend with an electrically and manually rotating thumb, 32 grip patterns (19 pre-defined), integrated pressure sensors that vibrate the residual limb to convey grip feel, IP64 splash resistance, USB-C charging in about an hour and 6-8 hours of use, and compatibility with third-party EMG pattern-recognition and direct-control systems. The same hand is being positioned as a robot end-effector for humanoids and collaborative robots. The company's stated mission is advanced bionics that stay affordable and accessible, and it prices and supports the hand for individual prosthesis users rather than only institutional buyers.
Research mapping
Physical AI / Actuation & Motion Control (L8) / Component
Evidence boundary
Original analysis and independent corroboration remain under development. Commercial scale and durable technical advantage remain under review.
What makes it defensible
The only bionic hand shipping with integrated touch sensing, 32 grip patterns and IP64 durability at under 500 g — the sensorized hand platform humanoid makers buy instead of building fingers themselves.
Position in the stack: Component / end-effector layer (L8). PSYONIC sells the hand, not the robot, and the position is defensible because the compliant finger mechanism, tendon drive and sensored brushless motors are patented (four filings listed by the company) and validated with amputee users over a decade — a humanoid OEM cannot shortcut that clinical iteration with a hardware spec.
Who buys it
Named customers: Mercedes-Benz (pilot), Apptronik (pilot), Koalaa (partnership)
Founding team
Aadeel Akhtar — Founder & CEO — PhD; started PSYONIC in November 2015 after prosthetics research at the University of Illinois, after meeting a young amputee in Pakistan; Forbes 30 Under 30 Healthcare 2016 and MIT Technology Review 35 Under 35 (2021).
SourceFinancing detail
- Last round
- Series A / equity crowdfunding + Shark Tank
Investors: Daymond John, Kevin O'Leary, Lori Greiner (Shark Tank)
Mapped funds and investors
Direct relationships supported by published evidence.
Reported holdings as-of
No sourced relationships mapped yet.
Disclosed investment history
No sourced relationships mapped yet.
Showing up to four relationships in each group. ETF weights describe the fund’s portfolio, not ownership of this company. Private investment history does not establish current ownership.